Hengrui Medicine (Jiangsu Hengrui Pharmaceuticals)
600276 · SSE · Health Care · Pharmaceuticals
About the company
Jiangsu Hengrui Medicine is one of China's largest research-based pharmaceutical companies, headquartered in Lianyungang, Jiangsu. It focuses on oncology, anaesthesiology, and contrast agents, and has become a significant developer of innovative biologics and small-molecule drugs for both domestic and international markets. Hengrui is listed on the Shanghai Stock Exchange.
| Exchange | SSE |
| Ticker | 600276 |
| Sector | Health Care · Pharmaceuticals |
| Indicative market cap USD | $25.00B |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
On its home market (SSE), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- The primary mainland exchanges are the Shanghai Stock Exchange and the Shenzhen Stock Exchange. The Shanghai Stock Exchange is the main venue for large-cap state-owned enterprises and blue chips, while the Shenzhen Stock Exchange hosts growth-oriented and technology companies including the ChiNext board. — official exchange listing
Availability information only. Not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in China
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only. Not investment advice. Verify with the exchange, the company's filings and your broker.